Kevin J. Whitehead

Cardiology
50 N Medical Dr
Salt Lake City,, UT 84132

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications

Health Care Utilization in Adults With Congenital Heart Disease: Population-Based Findings.

Health Care Utilization in Adults With Congenital Heart Disease: Population-Based Findings.

Journal: Birth defects research
Published: February 27, 2026

Clinical spectrum of hereditary hemorrhagic telangiectasia: data from the Comprehensive HHT Outcomes Registry of the US (CHORUS).

Clinical spectrum of hereditary hemorrhagic telangiectasia: data from the Comprehensive HHT Outcomes Registry of the US (CHORUS).

Journal: Blood
Published: January 07, 2026

Clinical Spectrum of Hereditary Hemorrhagic Telangiectasia: Data from the Comprehensive HHT Outcomes Registry of the US (CHORUS).

Clinical Spectrum of Hereditary Hemorrhagic Telangiectasia: Data from the Comprehensive HHT Outcomes Registry of the US (CHORUS).

Journal: Blood
Published: January 07, 2026

Characteristics associated with clinical response to pomalidomide in hereditary hemorrhagic telangiectasia.

Characteristics associated with clinical response to pomalidomide in hereditary hemorrhagic telangiectasia.

Journal: Blood advances
Published: December 23, 2025

Characteristics Associated with Clinical Response to Pomalidomide in Hereditary Hemorrhagic Telangiectasia.

Characteristics Associated with Clinical Response to Pomalidomide in Hereditary Hemorrhagic Telangiectasia.

Journal: Blood advances
Published: December 23, 2025

Pomalidomide for Hereditary Hemorrhagic Telangiectasia: After Trial Longitudinal Assessment Study (PATH-HHT ATLAS).

Pomalidomide for Hereditary Hemorrhagic Telangiectasia: After Trial Longitudinal Assessment Study (PATH-HHT ATLAS).

Journal: Blood advances
Published: September 10, 2025

Pomalidomide for hereditary hemorrhagic telangiectasia: after trial longitudinal assessment study (PATH-HHT ATLAS).

Pomalidomide for hereditary hemorrhagic telangiectasia: after trial longitudinal assessment study (PATH-HHT ATLAS).

Journal: Blood advances
Published: September 10, 2025

Comorbidity and Multimorbidity in Adults With Congenital Heart Disease: Findings From a Multi-Site Population-Based Study.

Comorbidity and Multimorbidity in Adults With Congenital Heart Disease: Findings From a Multi-Site Population-Based Study.

Journal: Birth defects research
Published: May 22, 2025

Validation and clinical application of the hereditary hemorrhagic telangiectasia-specific quality of life scale.

Validation and clinical application of the hereditary hemorrhagic telangiectasia-specific quality of life scale.

Journal: Journal of thrombosis and haemostasis : JTH
Published: May 06, 2025

Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia.

Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia.

Journal: The New England journal of medicine
Published: September 18, 2024

Investigation of the Genetic Determinants of Telangiectasia and Solid Organ Arteriovenous Malformation Formation in Hereditary Hemorrhagic Telangiectasia (HHT).

Investigation of the Genetic Determinants of Telangiectasia and Solid Organ Arteriovenous Malformation Formation in Hereditary Hemorrhagic Telangiectasia (HHT).

Journal: International journal of molecular sciences
Published: June 21, 2024

Helix-fixed leadless pacemaker implantation through a valve-in-valve tricuspid prosthesis via the femoral approach.

Helix-fixed leadless pacemaker implantation through a valve-in-valve tricuspid prosthesis via the femoral approach.

Journal: Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
Published: February 26, 2024
Showing 1-12 of 62

Last Updated: 09/26/2026